Novartis Investor
Working together, we can reimagine medicine to improve and extend people’s lives.
Invests into
Investors
Headquarters:
Basel
Industry:
pharmaceutical, healthcare
Employee Number:
76
Estimated Revenue:
US$ 45.44 billion
Investors Number:
1
Investment Stage:
N/A
Investor Type:
Accelerator
Funding Status:
IPO
Acquisitions Number:
Made Acquisitions
Number Of Exists:
21
Technology:
Biotechnology, Health Care, Medical, Pharmaceutical
Last Funding Type:
Grant
Founded Date:
1996-03-22
Total Funding:
6500000
Last Funding Date:
2018-02-14